TransEnterix Acquires Surgical Robotics Division of Sofar S.p.A.
TransEnterix has acquired the surgical robotics division of Sofar S.p.A., an Italian health care company, for $99.8 million.
Sofar has developed the TELELAP ALF-X advanced robotic system for minimally invasive laparoscopic surgery, which has an active CE Mark.
The acquisition will help the company accelerate the migration of traditional laparoscopic procedures to robotically assisted laparoscopy and address the trade-offs required of surgeons when using robots, according to Morrisville, N.C.-based TransEnterix.
Additionally, TransEnterix says robotic systems will bring economic value to hospital by reducing cost barriers through reduced capital acquisition cost or reduced per-procedure costs. — Michael Cipriano